×
More Charts Below
Acura Pharmaceuticals Share Holder Equity 2010-2021 | ACUR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Recent Trends
Acura Pharmaceuticals share holder equity from 2010 to 2021. Share holder equity can be defined as the sum of preferred and common equity items
Related Stocks
Company Name
Market
Cap
Teva Pharmaceutical Industries (TEVA)
$15.5B
Dr Reddy's Laboratories (RDY)
$11.4B
BridgeBio Pharma (BBIO)
$6.4B
Bausch Health Cos (BHC)
$1.9B
Supernus Pharmaceuticals (SUPN)
$1.7B
Amphastar Pharmaceuticals (AMPH)
$1.1B
Personalis (PSNL)
$282M
Taysha Gene Therapies (TSHA)
$254M
Assembly Biosciences (ASMB)
$75M
Sol-Gel Technologies (SLGL)
$15M
Evoke Pharma (EVOK)
$3M
Teligent (TLGT)
$0M